The Discounted Cash Flow (DCF) valuation of MaxCyte Inc (MXCT) is (9.81) USD. With the latest stock price at 1.04 USD, the upside of MaxCyte Inc based on DCF is -1043.1%.
Based on the latest price of 1.04 USD and our DCF valuation, MaxCyte Inc (MXCT) is a sell. selling MXCT stocks now will result in a potential gain of 1043.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 8.5% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (17.28) - (6.98) | (9.81) |
| Upside | -1762.0% - -771.3% | -1043.1% |